The acquisition allows for the delivery of more powerful insights to life science companies around the globe.
Within3 announces the company’s acquisition of Voxx Analytics. The acquisition will bring additional products and features to fulfill the company’s vision of identifying, engaging, and analyzing the most valuable insights to life science organizations worldwide.
“We are thrilled to welcome Voxx Analytics to the Within3 team,” said Lance Hill, Chief Executive Officer of Within3. “Voxx’s proven, customer-centric approach to identifying and answering important business questions for life science teams reinforces Within3’s dedication to successful business outcomes.”
“We are excited about the future and being a part of the next chapter at Within3,” said Anthony Page, Chief Executive Officer of Voxx Analytics. “The company’s unprecedented growth has proven how impactful virtual engagement is for life science organizations and adding our products to Within3 will only strengthen that impact.”
The acquisition is in line with Within3’s product innovation and infrastructure strategy spurred on by the company’s 2021 $100 million funding round led by Insight Partners. It also complements Within3’s acquisition of rMark Technologies earlier this year.
“Within3 is the exact type of company that we always knew we’d want to make an exit with,” said Daniel Vesely, President and Chief Operating Officer, of Voxx Analytics. “The company culture and values are directly aligned and our products fit perfectly into their portfolio, letting Within3 take the great company we built to the next level.”
The top 20 pharmaceutical companies and top medical device companies worldwide use Within3’s collaboration infrastructure to bring drugs and devices to market more quickly than ever.
